Journal of Clinical Pediatrics >
Clinical and prognostic significance of glomerular C3 deposition in children with primary membranous nephropathy
Received date: 2022-03-23
Online published: 2022-12-06
Objective To investigate the effect of glomerular C3 deposition on clinical and pathological features and prognosis of primary membranous nephropathy (PMN) in children. Methods The clinical data of children diagnosed with PMN by renal puncture from January 2008 to December 2020 were retrospectively analyzed. According to the intensity of glomerular C3 staining by immunofluorescence of renal pathology, the children were divided into low-intensity group (LI group, C3+) and high-intensity group (HI group, C3++ or +++). The clinicopathological features at baseline and treatment outcomes were compared between the two groups. The influencing factors of PMN progressing to end-stage renal disease (ESRD) were analyzed. Results A total of 213 children were included. There were 92 children in LI group and 121 children in HI group. Compared with the LI group, the HI group was older, the 24h urine protein quantity was higher, the serum albumin and eGFR levels were lower, the proportion of massive proteinuria, IgG immunofluorescence staining intensity +++, and IFTA moderate grade were higher, and the differences were statistically significant (P<0.05). The utilization rate of cyclophosphamide in LI group was higher than that in HI group, and the difference was statistically significant (P<0.05). After 43.0 (13.0-85.0) months of follow-up, 92 patients in the LI group completed the follow-up, and one patient progressed to ESRD. Sixty-eight children had complete response (CR) and partial response (PR), and 24 had no response (NR). After 57.0 (20.0-86.0) months of follow-up, 121 patients in HI group completed the follow-up, and five patients progressed to ESRD. Eighty-six children had CR and PR, and 35 had NR. The log-rank test showed that when baseline eGFR≤90 mL·min-1·1.73 m-2, the time of progression to ESRD was shorter, and the difference was statistically significant (P<0.05). Multivariate Cox regression analysis showed that increased eGFR at baseline was an independent protective factor for delaying the progression to ESRD (HR=0.96, 95% CI: 0.929-0.987), while glomerular C3 deposition was not associated with the occurrence of ESRD. Conclusions Extensive glomerular C3 deposition is not a predictor of renal failure in children with PMN.
Key words: primary membranous nephropathy; C3 deposition; child
Ren WANG , Zhengkun XIA , Pei ZHANG , Chunlin GAO . Clinical and prognostic significance of glomerular C3 deposition in children with primary membranous nephropathy[J]. Journal of Clinical Pediatrics, 2022 , 40(12) : 899 -904 . DOI: 10.12372/jcp.2022.22e0410
| [1] | Liu J, Zha Y, Zhang P, et al. The association between serum complement 4 and kidney disease progression in idiopathic membranous nephropathy: a multicenter retrospective cohort study[J]. Front Immunol, 2022, 13: 896654. |
| [2] | Wang YN, Feng HY, Nie X, et al. Recent advances in clinical diagnosis and pharmacotherapy options of membranous nephropathy[J]. Front Pharmacol, 2022, 13: 907108. |
| [3] | 中华医学会儿科学分会肾脏学组. 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55(10): 729-734. |
| [4] | 王忍. 儿童原发性膜性肾病研究进展[J]. 临床儿科杂志, 2021, 39(7): 549-552. |
| [5] | Alsharhan L, Beck LJ. Membranous nephropathy: core curriculum 2021[J]. Am J Kidney Dis, 2021, 77(3): 440-453. |
| [6] | Oto OA, Demir E, Mirioglu S, et al. Clinical significance of glomerular C3 deposition in primary membranous nephropathy[J]. J Nephrol, 2021, 34(2): 581-587. |
| [7] | 王楠楠. 儿童特发性膜性肾病诊疗进展[J]. 临床儿科杂志, 2021, 39(6): 476-480. |
| [8] | Fervenza FC, Glassock RJ. Molecular characterization of membranous nephropathy: quo vadis?[J]. J Am Soc Nephrol, 2022, 33(6): 1057-1059. |
| [9] | Teisseyre M, Cremoni M, Boyer-Suavet S, et al. Advances in the management of primary membranous nephropathy and rituximab-refractory membranous nephropathy[J]. Front Immunol, 2022, 13: 859419. |
| [10] | Horvatic I, Ljubanovic DG, Bulimbasic S, et al. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy[J]. Pathol Res Pract, 2012, 208(11): 662-667. |
| [11] | Chinello C, de Haan N, Capitoli G, et al. Definition of IgG subclass-specific glycopatterns in idiopathic membranous nephropathy: aberrant IgG glycoforms in blood[J]. Int J Mol Sci, 2022, 23(9): 4664. |
| [12] | Tsuboi N, Kawamura T, Miyazaki Y, et al. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy[J]. Nephrol Dial Transplant, 2011, 26: 3555-3560. |
| [13] | Ponticelli C, Patrizia P, Del Vecchio L, et al. The evolution of the therapeutic approach to membranous nephropathy[J]. Nephrol Dial Transplant, 2021, 36: 768-773. |
| [14] | Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy[J]. Kidney Int, 2004, 65(1): 148-153. |
| [15] | Cattran D. Management of membranous nephropathy: when and what for treatment[J]. J Am Soc Nephrol, 2005, 16(5): 1188-1194. |
| [16] | Sprangers B, Bomback AS, Cohen SD, et al. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center[J]. Am J Nephrol, 2012, 36(1): 78-89. |
| [17] | Spranger J, Homberg A, Sonnberger M, et al. Reporting guidelines for Delphi techniques in health sciences: a methodological review[J]. Z Evid Fortbild Qual Gesundhwes, 2022, 172: 1-11. |
/
| 〈 |
|
〉 |